Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer [NA]
A completed bioequivalence study comparing IG-001 to nab-paclitaxel in metastatic or locally recurrent breast cancer.
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: An Observational Time and Motion Study of Trastuzumab Subcutaneous (SC) and Intravenous (IV) Formulations in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (EBC)
An observational time-and-motion study comparing subcutaneous and intravenous trastuzumab in HER2-positive early breast cancer has completed…
-
CLINICAL_TRIALS trial_result · 2016-03-24Clinical Trial Update: A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy [Phase 3]
This is a Phase 3 trial comparing epoetin alfa plus standard supportive care to standard supportive care alone in anemic patients with metas…
-
CLINICAL_TRIALS other · 2016-03-24Clinical Trial Update: The Registration Program of BRCA1/2 Gene
This clinical trial update outlines the BRCA1/2 gene registration program in relation to breast cancer.
-
CLINICAL_TRIALS research · 2016-03-24Clinical Trial Update: The Effects of Indocyanine Green Angiography (IGA) on Deep Inferior Epigastric Artery Perforator (DIEP) Flap Design and Post-Operative Fat Necrosis
This clinical trial update discusses the use of indocyanine green angiography to influence Deep Inferior Epigastric Artery Perforator flap d…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: A Study to Evaluate Renal Safety of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Disease Due to Breast Cancer [Phase 3]
Phase 3 trial assessing renal safety of intravenous ibandronate (Bondronat) in patients with metastatic bone disease due to breast cancer ha…
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: Monitoring of Breast Tissue Change Due to Hormone Replacement Therapy in Post-menopausal Women Using OBS
This clinical trial update notes the completion of a study monitoring breast tissue changes in postmenopausal women on hormone replacement t…
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: Breast Cancer Risk Assessment Using Optical Breast Spectroscopy (OBS)
The study evaluating optical breast spectroscopy as a risk assessment tool for breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer [Phase 2]
A Phase 2 neoadjuvant trial in breast cancer evaluating chemotherapy plus lapatinib and trastuzumab has completed, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer [Phase 1]
A Phase 1 study evaluating temperature-sensitive liposomal doxorubicin with hyperthermia in women with locally recurrent breast cancer was t…
-
CLINICAL_TRIALS trial_result · 2016-03-21Clinical Trial Update: Tivantinib in Treating Patients With Recurrent or Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluating tivantinib for recurrent or metastatic breast cancer has completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer [Phase 2]
Phase 2 trial evaluating azacitidine in combination with entinostat in advanced breast cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: First Line Metastatic Breast Cancer Treatment (ESMERALDA) [Phase 2]
A Phase 2 trial (ESMERALDA) evaluating first-line treatment for metastatic breast cancer has completed.
-
CLINICAL_TRIALS other · 2016-03-17Clinical Trial Update: Edema Control in Patients With Breast Cancer-comparison of Manual Lymph Drainage and Epidermis Fascia Taping [NA]
Clinical trial update on edema control in breast cancer patients comparing manual lymph drainage to epidermis fascia tapping; status is UNKN…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12 [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a dendritic cell/tumor fusion vaccine with interleukin-12 for breast cancer was terminated, with resul…
-
CLINICAL_TRIALS research · 2016-03-16Clinical Trial Update: A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers
A study investigating how gene polymorphisms relate to normal tissue radiation injury in patients treated for several cancers; current statu…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Non-Invasive Imaging for Cording in Breast Cancer Patients [NA]
This document reports a completed clinical trial evaluating non-invasive imaging for cording in breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2016-03-15Clinical Trial Update: Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial evaluating weekly cilengitide in combination with paclitaxel in adults with advanced, unresectable solid tumors, including bre…
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer [Phase 2]
Phase 2 trial evaluating preoperative MM-121 with Paclitaxel in HER2-negative breast cancer completed; results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: A Study to Assess the Ability of a Novel Endocrine Treatment for Breast Cancer, Irosustat, to Slow Down Cancer Growth [Phase 2]
A Phase 2 trial evaluating Irosustat as an endocrine therapy for breast cancer to slow tumor growth was terminated. The study was sponsored …
-
CLINICAL_TRIALS trial_result · 2016-03-11Clinical Trial Update: Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer [Phase 2]
This entry reports on a Phase 2 trial of exemestane plus goserelin for premenopausal women with metastatic breast cancer. The study status i…
-
CLINICAL_TRIALS trial_result · 2016-03-11Clinical Trial Update: Chemotherapy in Treating Patients With Breast Cancer [Phase 1, Phase 2]
This document reports an update on a Phase 1/2 clinical trial investigating chemotherapy in patients with breast cancer, which has completed…
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: Dose Escalation Followed by Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 dose-escalation study tested everolimus (RAD001) in combination with trastuzumab for HER2-positive metastatic breast cancer; the…
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer [Phase 1, Phase 2]
This clinical trial update reports Phase 1/2 results for the combination of ixabepilone and liposomal doxorubicin in advanced ovarian and re…
-
CLINICAL_TRIALS research · 2016-03-09Clinical Trial Update: Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children [NA]
Clinical trial status update noting the completion of a telephone-based educational intervention study designed to improve communication bet…